4.74
전일 마감가:
$4.60
열려 있는:
$4.67
하루 거래량:
62,228
Relative Volume:
0.81
시가총액:
$142.45M
수익:
$8.98M
순이익/손실:
$-31.39M
주가수익비율:
-3.5373
EPS:
-1.34
순현금흐름:
$-24.83M
1주 성능:
+11.53%
1개월 성능:
-19.25%
6개월 성능:
-36.63%
1년 성능:
-49.09%
프로파운드 메디컬 Stock (PROF) Company Profile
명칭
Profound Medical Corp
전화
647-476-1350
주소
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
PROF을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PROF
Profound Medical Corp
|
4.74 | 142.75M | 8.98M | -31.39M | -24.83M | -1.34 |
![]()
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-23 | 개시 | Lake Street | Buy |
2024-07-16 | 업그레이드 | Stifel | Hold → Buy |
2023-11-28 | 개시 | Stifel | Hold |
2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
2020-09-15 | 개시 | Jefferies | Buy |
모두보기
프로파운드 메디컬 주식(PROF)의 최신 뉴스
Is it too late to sell Profound Medical Corp.2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Will Profound Medical Corp. outperform the marketMarket Performance Report & Daily Market Momentum Tracking - Newser
Evaluating Profound Medical Corp. with trendline analysisQuarterly Earnings Summary & Intraday High Probability Setup Alerts - Newser
Leading vs lagging indicators on Profound Medical Corp. performanceMarket Activity Summary & Technical Entry and Exit Alerts - Newser
Volatility clustering patterns for Profound Medical Corp.July 2025 Momentum & AI Enhanced Execution Alerts - Newser
What candlestick patterns are forming on Profound Medical Corp.2025 Market Overview & Precise Buy Zone Tips - Newser
Custom watchlist performance reports with Profound Medical Corp.2025 Market Overview & Fast Moving Stock Watchlists - Newser
Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Call Transcript - MSN
Published on: 2025-08-19 16:58:38 - Newser
Is now a turning point for Profound Medical Corp.2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Analysts Spot Bullish Divergence in Profound Medical Corp.Weekly Market Summary & Consistent Profit Trading Strategies - newsyoung.net
Profound Medical is a buy, Leede says - Cantech Letter
Using Bollinger Bands to evaluate Profound Medical Corp.Buy Signal & Safe Capital Investment Plans - Newser
How hedge fund analytics apply to Profound Medical Corp. stock2025 Earnings Impact & Step-by-Step Trade Execution Guides - Newser
How sentiment analysis helps forecast Profound Medical Corp.2025 Market Overview & Daily Risk Controlled Trade Plans - Newser
Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence - MSN
Profound Medical: Smokes Is Everywhere, Initiate At Sell (NASDAQ:PROF) - Seeking Alpha
Is Profound Medical Corp. Forming a Bottom PatternLong Setup & Scalable Portfolio Growth Methods - sundaytimes.kr
Why Profound Medical Corp. stock attracts strong analyst attentionWatch List & Community Verified Trade Alerts - 선데이타임즈
Published on: 2025-08-18 05:28:45 - beatles.ru
Detecting support and resistance levels for Profound Medical Corp.2025 Top Decliners & Daily Profit Focused Stock Screening - Newser
Using fundamentals and technicals on Profound Medical Corp.Recession Risk & Low Risk High Reward Ideas - Newser
Will Profound Medical Corp. announce a stock split2025 Winners & Losers & Real-Time Volume Analysis - mustnews.co.kr
Heatmap analysis for Profound Medical Corp. and competitorsCPI Data & Risk Controlled Swing Trade Alerts - Newser
Tick level data insight on Profound Medical Corp. volatilityMarket Sentiment Review & Verified Technical Trade Signals - Newser
Risk adjusted return profile for Profound Medical Corp. analyzedTrade Volume Report & Risk Controlled Stock Pick Alerts - Newser
How to integrate Profound Medical Corp. into portfolio analysis toolsQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - Newser
Profound Medical Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Profound Medical's Market Cap Drops To CA$227m Leaving Insiders With Losses - simplywall.st
Profound Medical Reports Q2 2025 Growth and New Innovations in Prostate Treatment - MSN
Candlestick signals on Profound Medical Corp. stock today2025 Dividend Review & Consistent Return Strategy Ideas - Newser
Profound Medical Corp. shares fall 21.66% intraday after posting a wider loss for Q2 2025. - AInvest
Profound Medical's 21.66% Plunge: A Bearish Surge Amid Sector Turbulence? - AInvest
Profound Medical Corp Q2 2025 Earnings: Revenue Misses Estimate, EPS at -$0.52 - AInvest
ProFound Medical's Strategic Reimagining: Navigating the Urology Medtech Landscape for Long-Term Value - AInvest
Profound Medical Corp (PROF) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Profound Medical Announces Second Quarter 2025 Financial Results - 富途牛牛
Is Profound Medical Corp. the Top Chart Pick This WeekEarnings Overview Report & Consistent Return Investment Signals - thegnnews.com
ProFound Medical's Strategic Pivot: Capital Sales and the Road to Sustainable Growth in 2025 - AInvest
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
프로파운드 메디컬 주식 (PROF) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
자본화:
|
볼륨(24시간):